China Pharma Holdings (CPHI) Retained Earnings (2010 - 2026)
China Pharma Holdings (CPHI) posted Retained Earnings of $12.0 million for Q1 2026, down 79.47% on a QoQ basis from $58.5 million in Q4 2025, and up 6.08% year-over-year from $11.3 million in Q1 2025.
China Pharma Holdings (CPHI) Retained Earnings (2010 - 2026) Analysis & Trends
China Pharma Holdings' Retained Earnings history runs 17 years deep, the most recent figure standing at $12.0 million for Q1 2026.
- Quarterly Retained Earnings rose 6.08% year-over-year to $12.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.0 million (up 6.08% YoY) and the FY2025 annual result came in at $58.5 million, up 417.12% from the prior year.
- Retained Earnings was $12.0 million for Q1 2026 at China Pharma Holdings, down from $58.5 million in the prior quarter.
- Across five years, Retained Earnings topped out at $58.5 million in Q4 2025 and bottomed at -$46.0 million in Q3 2025.
- A 5-year average of $2.0 million and a median of $11.4 million in 2024 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 417.12% in 2025, while the deepest fall reached 499.21% in 2025.
- China Pharma Holdings' Retained Earnings stood at -$36.2 million in 2022, then surged by 197.43% to $35.3 million in 2023, then plunged by 67.92% to $11.3 million in 2024, then soared by 417.12% to $58.5 million in 2025, then slumped by 79.47% to $12.0 million in 2026.
- Business Quant data shows CPHI's Retained Earnings at $12.0 million in Q1 2026, $58.5 million in Q4 2025, and -$46.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | 12.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.02 Mn |
| Dec 31, 2025 | 58.54 Mn |
| Sep 30, 2025 | -46.00 Mn |
| Jun 30, 2025 | -45.34 Mn |
| Mar 31, 2025 | 11.33 Mn |
| Dec 31, 2024 | 11.32 Mn |
| Sep 30, 2024 | 11.52 Mn |
| Jun 30, 2024 | 37.69 Mn |
| Mar 31, 2024 | 11.43 Mn |
| Dec 31, 2023 | 35.28 Mn |
| Sep 30, 2023 | -38.06 Mn |
| Jun 30, 2023 | -37.28 Mn |
| Mar 31, 2023 | 29.49 Mn |
| Dec 31, 2022 | -36.21 Mn |
| Sep 30, 2022 | 26.34 Mn |
| Jun 30, 2022 | -34.16 Mn |
| Mar 31, 2022 | 25.94 Mn |
| Dec 31, 2021 | 25.65 Mn |
| Sep 30, 2021 | 25.65 Mn |
| Jun 30, 2021 | -30.43 Mn |